CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
62.29
+1.56 (2.57%)
May 29, 2026, 4:00 PM EDT - Market closed
CG Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5.07 | 4.04 | 1.14 | 0.2 | 0.19 | 10.36 | |
Revenue Growth (YoY) | 820.33% | 254.70% | 458.33% | 6.81% | -98.16% | - |
Cost of Revenue | 7.61 | 4.65 | - | - | - | - |
Gross Profit | -2.54 | -0.61 | 1.14 | 0.2 | 0.19 | 10.36 |
Selling, General & Admin | 79.52 | 73.53 | 33.7 | 9.9 | 6.41 | 4.65 |
Research & Development | 132.9 | 116.64 | 82.1 | 45.75 | 29.03 | 18.32 |
Total Operating Expenses | 212.42 | 190.17 | 115.81 | 55.65 | 35.44 | 22.96 |
Operating Income | -214.96 | -190.77 | -114.67 | -55.45 | -35.25 | -12.61 |
Interest Income | 28.47 | 29.93 | 26.62 | 6.9 | - | - |
Interest Expense | - | - | - | - | -0 | -0.45 |
Other Non-Operating Income (Expense) | -0.26 | -0.15 | 0 | -0.06 | -0.2 | 0.22 |
Total Non-Operating Income (Expense) | 28.21 | 29.78 | 26.63 | 6.84 | -0.2 | -0.23 |
Pretax Income | -186.75 | -161 | -88.04 | -48.61 | -35.44 | -12.84 |
Net Income | -186.75 | -161 | -88.04 | -67.8 | -43.79 | -18.38 |
Net Income Attributable to Preferred Dividends | - | - | - | 19.19 | 8.35 | 5.54 |
Net Income to Common | -186.75 | -161 | -88.04 | -67.8 | -43.79 | -18.38 |
Shares Outstanding (Basic) | 79 | 77 | 62 | 4 | 4 | 3,651 |
Shares Outstanding (Diluted) | 79 | 77 | 62 | 4 | 4 | 3,651 |
Shares Change (YoY) | 13.80% | 23.69% | 1343.03% | 15.77% | -99.90% | - |
EPS (Basic) | -2.33 | -2.08 | -1.41 | -15.65 | -11.71 | -5.04 |
EPS (Diluted) | -2.33 | -2.08 | -1.41 | -15.65 | -11.71 | -5.04 |
Shares Outstanding | 88.01 | 80.69 | 76.15 | 5.22 | 3.84 | 3.71 |
Free Cash Flow | -160.43 | -132.48 | -78.95 | -45.68 | -29.82 | -13.75 |
Free Cash Flow Per Share | -2.02 | -1.71 | -1.26 | -10.55 | -7.97 | -0.00 |
Gross Margin | -50.05% | -15.02% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -4238.99% | -4722.13% | -10067.30% | -27180.90% | -18453.40% | -121.70% |
Profit Margin | -3682.61% | -3985.02% | -7729.50% | -23827.00% | -18556.50% | -123.95% |
FCF Margin | -3163.75% | -3279.21% | -6931.26% | -22391.70% | -15611.50% | -132.76% |
EBITDA | -212.7 | -189.33 | -114.63 | -55.43 | -35.23 | -12.6 |
EBITDA Margin | -4194.38% | -4686.36% | -10064.40% | -27172.50% | -18445.50% | -121.61% |
EBIT | -214.96 | -190.77 | -114.67 | -55.45 | -35.25 | -12.61 |
EBIT Margin | -4238.99% | -4722.13% | -10067.30% | -27180.90% | -18453.40% | -121.70% |